# OnCo record napoli-3 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/napoli-3/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "napoli-3", "NCT04083235" ;
  schema:name "NAPOLI 3"@en ;
  schema:description "The first head-to-head trial of the two chemotherapy backbones, won narrowly by the four-drug regimen."@en ;
  schema:url <https://onco.cc/trials/napoli-3/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04083235>, <https://doi.org/10.1016/S0140-6736(23)01366-1>, <https://api.fda.gov/drug/label.json?search=openfda.brand_name:%22ONIVYDE%22> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2020-02-11" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/metastatic-pdac/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/platinum/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/nalirifox/>, <https://onco.cc/drugs/gemcitabine-nab-paclitaxel/> ;
  onco:companies <https://onco.cc/companies/ipsen/> ;
  onco:trials <https://onco.cc/trials/prodige-4-accord-11/>, <https://onco.cc/trials/napoli-1/>, <https://onco.cc/trials/mpact/>, <https://onco.cc/trials/canstem111p/> ;
  onco:people <https://onco.cc/people/zev-wainberg/> .